News | Radiation Therapy | July 21, 2017

El Camino Hospital to Offer Calypso 4-D Localization System

FDA-approved device targets more soft tissue cancers using precise technology

El Camino Hospital to Offer Calypso 4-D Localization System

July 21, 2017 — El Camino Hospital (Mountain View, Calif.) announced the installation of a new Calypso 4-D Localization System and will soon be able to treat patients with certain soft tissue cancers using this precise radiation technology.

The Calypso system is a radiation therapy treatment device that allows for real-time tracking of tumors as they move within a patient’s soft tissues. It has been in use for a decade to treat prostate cancer, however it was only recently approved by the U.S. Food and Drug Administration (FDA) for use against other soft tissue cancers, such as pancreatic, breast, liver, lung, gynecological and more. El Camino Hospital will be the first hospital in the San Francisco Bay Area to expand the Calypso’s use to other cancer sites.

“Our biggest challenge as radiation oncologists is that our targets, the tumors, in the body move,” said Robert Sinha, M.D., medical director of radiation oncology at El Camino Hospital. “The only equipment that allows you to track that movement continuously is the Calypso system. By using its precise tracking technology, we can confidently keep the radiation beam on the tumor and therefore, irradiate less normal tissue.

“While this process has been well established for use against prostate cancer, its approval for expanded use on other soft tissue cancers is groundbreaking for our patients. Its targeted image guidance will improve the patient experience and allow doctors to consistently target only tumor tissue, reducing the side effects of radiation therapy,” he added.

The new device was funded by the El Camino Hospital Foundation. In addition to the Calypso system, El Camino Hospital oncologists have access to radiation therapy technology that includes the CyberKnife, RapidArc, intensity-modulated radiation therapy (IMRT), brachytherapy and more. The Cancer Center at El Camino Hospital offers numerous radiation treatment options and works with each patient to create a unique plan that will work best for them.

For more information: www.varian.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...